TLK1 as a therapeutic target in TMZ resistant glioblastoma using small molecule inhibitor
Crossref DOI link: https://doi.org/10.1038/s41598-025-86599-3
Published Online: 2025-04-26
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Priya, Bhanu
Kirubakaran, Sivapriya
Text and Data Mining valid from 2025-04-26
Version of Record valid from 2025-04-26
Article History
Received: 9 October 2024
Accepted: 13 January 2025
First Online: 26 April 2025
Declarations
:
: The authors declare no competing interests.